Search Results - "HAIYONG HAN"
-
1
RNA Interference to Knock Down Gene Expression
Published in Methods in molecular biology (Clifton, N.J.) (2018)“…RNA interference (RNAi) is a biological process by which double-stranded RNA (dsRNA) induces sequence-specific gene silencing by targeting mRNA for…”
Get more information
Journal Article -
2
Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression
Published in Carcinogenesis (New York) (01-10-2017)“…Development of resistance to chemotherapeutic drugs is a major challenge in the care of patients with pancreatic ductal adenocarcinoma (PDAC). Acquired…”
Get full text
Journal Article -
3
Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer
Published in Clinical cancer research (01-08-2015)“…Pancreatic ductal adenocarcinoma (PDAC) is characterized by high levels of fibrosis, termed desmoplasia, which is thought to hamper the efficacy of…”
Get full text
Journal Article -
4
Perineural invasion and associated pain in pancreatic cancer
Published in Nature reviews. Cancer (01-10-2011)“…Key Points Perineural invasion (PNI) is the process through which cancer cells invade the perineural spaces of surrounding nerves and is not simply the…”
Get full text
Journal Article -
5
Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions
Published in Genome medicine (29-09-2020)“…Solid tumors such as pancreatic ductal adenocarcinoma (PDAC) comprise not just tumor cells but also a microenvironment with which the tumor cells constantly…”
Get full text
Journal Article -
6
KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism
Published in Cancer cell (12-11-2018)“…Our recent ERK1/2 inhibitor analyses in pancreatic ductal adenocarcinoma (PDAC) indicated ERK1/2-independent mechanisms maintaining MYC protein stability. To…”
Get full text
Journal Article -
7
Pancreatic acinar cell carcinoma: A review on molecular profiling of patient tumors
Published in World journal of gastroenterology : WJG (07-12-2017)“…Pancreatic carcinomas with acinar differentiation are rare,accounting for 1%-2% of adult pancreatic tumors; they include pancreatic acinar cell…”
Get full text
Journal Article -
8
Inhibition of ROCK1 kinase modulates both tumor cells and stromal fibroblasts in pancreatic cancer
Published in PloS one (25-08-2017)“…ROCK, or Rho-associated coiled coil-containing protein kinase, is a member of the AGC kinase family and has been shown to play a role in cell migration, ECM…”
Get full text
Journal Article -
9
Blocking Nerve Growth Factor Signaling Reduces the Neural Invasion Potential of Pancreatic Cancer Cells
Published in PloS one (28-10-2016)“…Perineural invasion (PNI) is thought to be one of the factors responsible for the high rate of tumor recurrence after surgery and the pain generation…”
Get full text
Journal Article -
10
Aronia Berry Extract Modulates MYD88/NF-kB/P-Glycoprotein Axis to Overcome Gemcitabine Resistance in Pancreatic Cancer
Published in Pharmaceuticals (Basel, Switzerland) (09-07-2024)“…Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease with poor survival rates, primarily due to the limited effectiveness of gemcitabine…”
Get full text
Journal Article -
11
Assessment of folate receptor alpha and beta expression in selection of lung and pancreatic cancer patients for receptor targeted therapies
Published in Oncotarget (12-01-2018)“…A number of folate receptor (FR) targeted small molecular drugs and monoclonal antibodies have been introduced into clinical trials to treat FR positive…”
Get full text
Journal Article -
12
Berberine Overcomes Gemcitabine-Associated Chemoresistance through Regulation of Rap1/PI3K-Akt Signaling in Pancreatic Ductal Adenocarcinoma
Published in Pharmaceuticals (Basel, Switzerland) (28-09-2022)“…Gemcitabine (Gem)-based chemotherapy is one of the first-line treatments for pancreatic ductal adenocarcinoma (PDAC). However, its clinical effect is limited…”
Get full text
Journal Article -
13
Increasing Stress to Induce Apoptosis in Pancreatic Cancer via the Unfolded Protein Response (UPR)
Published in International journal of molecular sciences (29-12-2022)“…High rates of cell proliferation and protein synthesis in pancreatic cancer are among many factors leading to endoplasmic reticulum (ER) stress. To restore…”
Get full text
Journal Article -
14
Parallel Accumulation of Tumor Hyaluronan, Collagen, and Other Drivers of Tumor Progression
Published in Clinical cancer research (01-10-2018)“…The tumor microenvironment (TME) evolves to support tumor progression. One marker of more aggressive malignancy is hyaluronan (HA) accumulation. Here, we…”
Get full text
Journal Article -
15
Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second look
Published in Cancer discovery (01-09-2011)“…Increased extracellular matrix (ECM) deposition is a characteristic observed in many solid tumors. Increased levels of one ECM component-namely, hyaluronan…”
Get more information
Journal Article -
16
Advanced glycation end product (AGE) targeting antibody SIWA318H is efficacious in preclinical models for pancreatic cancer
Published in Scientific reports (07-10-2023)“…SIWA318H is a novel monoclonal antibody that selectively targets an advanced glycation end product biomarker found in damaged/dysfunctional cells exhibiting…”
Get full text
Journal Article -
17
Ultra-Sensitive Automated Profiling of EpCAM Expression on Tumor-Derived Extracellular Vesicles
Published in Frontiers in genetics (17-12-2019)“…Extracellular vesicles (EVs) are abundant in most biological fluids and considered promising biomarker candidates, but the development of EV biomarker assays…”
Get full text
Journal Article -
18
Synergistic Effect between Erlotinib and MEK Inhibitors in KRAS Wild-Type Human Pancreatic Cancer Cells
Published in Clinical cancer research (01-05-2011)“…The combination of erlotinib and gemcitabine has shown a small but statistically significant survival advantage when compared with gemcitabine alone in…”
Get full text
Journal Article -
19
Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased β2 adrenergic agonist
Published in Scientific reports (07-03-2022)“…Metabolic reprogramming contributes to oncogenesis, tumor growth, and treatment resistance in pancreatic ductal adenocarcinoma (PDAC). Here we report the…”
Get full text
Journal Article -
20
Tumor and Peritoneum-Associated Macrophage Gene Signature as a Novel Molecular Biomarker in Gastric Cancer
Published in International journal of molecular sciences (01-04-2024)“…A spectrum of immune states resulting from tumor resident macrophages and T-lymphocytes in the solid tumor microenvironment correlates with patient outcomes…”
Get full text
Journal Article